| FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk |
| Request for an American Board of Cardiovascular Medicine denied—cardiology groups ‘deeply disappointed’ |
| Why cardiac CT adoption remains low among primary care providers |
| Surgeons make history, perform world’s first living mitral valve replacement |
| FDA sued over ‘reckless and arbitrary’ semaglutide decision |
| Teleflex to acquire Biotronik’s vascular intervention business for $791M, split into 2 separate entities |
| FDA clears Google smartwatch tech that calls 911 when a user’s heart stops |
| Popular TAVR valves linked to comparable long-term outcomes |
| Wearable heart device company to go public, raise up to $155M |
| Detecting coronary inflammation on CT imaging could reshape preventive cardiology |
| ‘A significant milestone’: First US patients receive doses of new PET radiotracer for CAD |
| Medtronic enrolls first patient in new coronary DCB trial—data could lead to FDA approval |
| Know your options: What cardiologists recommend when alternative access is required for TAVR |
| Heart surgery during pregnancy: Tracking the safety of a rare, sometimes unavoidable, scenario |
| An updated look at the use of cerebral embolic protection devices during TAVR |
| AI leader Heartflow enters new era focused on delivering personalized care for CAD patients |
| Cardiovascular societies support Medicare coverage for renal denervation |
| Continuation of 99mTc-PYP shortage prompts need for alternative cardiac amyloidosis imaging |
| New drug therapies targeting Lp(a) could be a breakthrough in cardiovascular care |
| FDA announces Class I recall of Boston Scientific pacemakers—replacement may be necessary |
| Surgeons first in world to perform open heart surgery on baby mid-delivery |
| FDA ends semaglutide shortage, closing the door on compounded Wegovy, Ozempic |
| American Heart Association highlights importance of NIH as battle over Trump funding cuts continues |
| Cardiologist questions FDA’s approval process for high-risk medical devices |
| Getinge ending production of cardiopulmonary surgical perfusion systems |
| Embracing the future: James Min left academia to push for a paradigm shift in preventive cardiology |
| FDA approves first rapid-acting insulin biosimilar for diabetes |
| Aspartame linked to surging insulin levels, fatty plaques and inflammation |
| Sotagliflozin the first drug of its kind to limit heart attacks, strokes in high-risk patients |
| CABG still the ‘gold standard’ for revascularization in patients with 3-vessel CAD and CKD |
| Osteoporosis drug shows potential to treat heart disease |
| Johnson & Johnson resumes PFA rollout after stopping to review safety concerns |
| Veterans with heart disease often receive better care through VA than they would elsewhere |
| Opportunistic imaging detects signs of heart disease in lung cancer patients |
| LAAO or DOAC? Mayo Clinic AI helps guide treatment of AFib patients |
| FDA announces new recall of Johnson & Johnson heart pumps over safety concerns |
| CABG, TAVR top list of most lucrative heart procedures for hospitals |
| Cardiologists recommend AVR for asymptomatic severe AS—TAVR and surgery both viable options |
| HeartBeam raising $10M for FDA-cleared health tech with public offering |
| Johnson & Johnson MedTech launches new large-bore catheter system for stroke |
| Use of biolimus-coated balloons during PCI not as effective as paclitaxel devices |
| Report: Johnson & Johnson wants to sell its stroke business for more than $1B |
| Final decision on the creation of a new cardiovascular board expected soon |
| Interventional heart failure: An evolving cardiology subspecialty with a bright future |
| ACC president details key advocacy efforts in cardiology |
| Novartis to acquire drugmaker behind new heart therapy for up to $3.1B |
| Treating a broken heart: Beta-blockers improve survival in patients with takotsubo syndrome |
| Benzodiazepine use before heart surgery: Should it be embraced or restricted? |
| Physicians are leaning into supra-annular, self-expanding TAVR valves for women and small-annulus patients |
| Women with severe aortic stenosis remain underdiagnosed, undertreated—here’s how cardiologists can make a difference |
| Family of heart patient who died after missing medications in jail settles lawsuit |
| ASE shares new guidelines for ultrasound-guided vascular access |
| AI brings cardiology, neurology teams together to boost care for stroke patients |
| FDA warns that atherectomy devices are breaking during use—30 serious injuries, 4 deaths reported |
| COVID-19 linked to accelerated plaque growth, long-term risk of heart attack or stroke |
| Post-stroke follow-up care considerably worse for women than men |
| THT 2025: Late-breaking clinical trials announced for CRF’s heart failure conference |
| FDA warns that smartphone-compatible diabetes devices may not work properly |
| Heart failure patients see benefits from home-based rehab |
| Oklahoma cardiologist and his clinic pay $270K to settle whistleblower lawsuit |
| Be good to your teeth: Regular flossing reduces risk of stroke, AFib |
| Ross procedure linked to high levels of safety, effectiveness after 20 years |
| Nearly half of U.S. adults are wrong about aspirin |
| TAVR patients admitted on weekend face greater risk of death, complications |
| More than words: AI takes NLP to the next level to identify signs of heart failure |
| Key details on the use of ICE to guide structural heart procedures |
| Cardiologists help highlight ‘severe consequences’ of peripheral artery disease |
